Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| SUNESIS PHARMACEUTICALS INC | 5,623,815 | reported | 24 Jul 2015 | tx 12+1,665,830−2,301,532 |
| Epizyme, Inc. | 3,370,562 | reported | 12 Jan 2016 | tx 11+4,231,950−10,942,859 |
| HYPERION THERAPEUTICS INC | 1,879,836 | reported | 18 Oct 2013 | tx 18+11,276−275,906 |
| Enliven Therapeutics, Inc. | 703,380 | reported | 16 Mar 2020 | tx 9+718,837−4,430,654 |
1 purchase reported after at least 12 months of silence — most recent on 12 Jan 2016.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Mar 2020 | CONVERSION | Enliven Therapeutics, Inc. | 690,232 | — | |
| 16 Mar 2020 | CONVERSION | Enliven Therapeutics, Inc. | 13,148 | — | |
| 16 Mar 2020 | CONVERSION | Enliven Therapeutics, Inc. | 16,103 | — | deriv |
| 16 Mar 2020 | CONVERSION | Enliven Therapeutics, Inc. | 3,220,915 | — | deriv |
| 16 Mar 2020 | CONVERSION | Enliven Therapeutics, Inc. | 5,372 | — | deriv |
| 16 Mar 2020 | CONVERSION | Enliven Therapeutics, Inc. | 281,878 | — | deriv |
| 16 Mar 2020 | CONVERSION | Enliven Therapeutics, Inc. | 845,008 | — | deriv |
| 16 Mar 2020 | CONVERSION | Enliven Therapeutics, Inc. | 61,378 | — | deriv |
| 16 Mar 2020 | GRANT_AWARD | Enliven Therapeutics, Inc. | 15,457 | 0.00 USD | deriv |
| 12 Jan 2016 | PURCHASE | Epizyme, Inc. | 10,389 | 9.00 USD | |
| 12 Jan 2016 | PURCHASE | Epizyme, Inc. | 545,166 | 9.00 USD | first after silence |
| 24 Jul 2015 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 20,766 | 1.32 USD | |
| 24 Jul 2015 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 544,893 | 1.32 USD | |
| 24 Jul 2015 | SALE | SUNESIS PHARMACEUTICALS INC | 207,938 | 3.46 USD | |
| 24 Jul 2015 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 10,383 | 1.32 USD | |
| 24 Jul 2015 | SALE | SUNESIS PHARMACEUTICALS INC | 7,925 | 3.46 USD | |
| 24 Jul 2015 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 1,089,788 | 1.32 USD | |
| 24 Jul 2015 | SALE | SUNESIS PHARMACEUTICALS INC | 3,962 | 3.46 USD | |
| 24 Jul 2015 | SALE | SUNESIS PHARMACEUTICALS INC | 415,877 | 3.46 USD | |
| 24 Jul 2015 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 544,893 | 0.00 USD | deriv |
| 24 Jul 2015 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 20,766 | 0.00 USD | deriv |
| 24 Jul 2015 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 1,089,788 | 0.00 USD | deriv |
| 24 Jul 2015 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 10,383 | 0.00 USD | deriv |
| 10 Feb 2014 | SALE | Epizyme, Inc. | 457,940 | 29.25 USD | |
| 10 Feb 2014 | SALE | Epizyme, Inc. | 8,727 | 29.25 USD |